Profil

Libon Florence

Département des sciences cliniques

See author's contact details
ORCID
0009-0007-5829-7678
Main Referenced Co-authors
Nikkels, Arjen  (46)
Dezfoulian, Bita  (26)
Lebas, Eve  (14)
Cavalier, Etienne  (10)
Seidel, Laurence  (7)
Main Referenced Keywords
Dermatite atopique (4); Vitamin D (4); Psoriasis (3); UVB (3); Biothérapies (2);
Main Referenced Unit & Research Centers
Department of Dermatology, Liège Univertsity hospital, CHU du Sart-Tilman, Liège, Belgium (1)
Main Referenced Disciplines
Dermatology (55)
Laboratory medicine & medical technology (2)
Anesthesia & intensive care (1)
Endocrinology, metabolism & nutrition (1)
General & internal medicine (1)

Publications (total 61)

The most downloaded
281 downloads
Absil, G., DAMSIN, T., LEBAS, E., Libon, F., SOMJA, J., COLLINS, P., REGINSTER, M.-A., QUATRESOOZ, P., RORIVE, A., MARCHAL, N., JACQUEMIN, D., BOUS, A., PIRET, P., & NIKKELS, A. (May 2021). Le mélanome: le trajet de soins du patient: Du diagnostic au traitement. Revue Médicale de Liège, 76 (5-6), 489-495. https://hdl.handle.net/2268/293259

The most cited

81 citations (OpenCitations)

LIBON, F., CAVALIER, E., & NIKKELS, A. (2013). Skin color is relevant to vitamin D synthesis. Dermatology, 227 (3), 250-4. doi:10.1159/000354750 https://hdl.handle.net/2268/166075

Libon, F., A. Bernede-astruc, M. Bourrel-bouttaz, & P-A Darene. (2024). Hygiène, Emollients, Dermocorticoïdes, le trépied indispensable de la dermatite atopique. In Revue d'allergologie pratique. SAS ANAFORCAL.
Peer reviewed

Libon, F. (2024). Biomarkers and surrogate markers in clinical Dermatology trials.

Libon, F., Coline Jaulent-Darmaisin, Ridha Charfi, & Sophie Collin. (2023). Biothérapies et petites molécules en dermato-allergologie: Pour qui? Comment? In Revue d'allergologie pratique. SAS ANAFORCAL.

Libon, F. (2023). Les purpuras. (Cours inter-universitaires).

Libon, F. (01 July 2022). Les traitements de la dermatite atopique [Paper presentation]. Congrès annuel de recherche dermatologique, Namur, Belgium.

Absil, G., Lebas, E., Libon, F., El Hayderi, L., Dezfoulian, B., & Nikkels, A. (2022). Scabies and thérapeutic resistance: Current knowledge and future perspectives. Journal of the European Academy of Dermatology and Venereology. doi:10.1002/jvc2.25

Libon, F. (11 March 2022). Food allergy testing [Paper presentation]. Belgian Dermatology Days, Belgium.

Damsin, T., Libon, F., Nikkels, A., & Dezfoulian, B. (2022). Dermatite atopique: La révolution thérapeutique est en marche. Revue Médicale de Liège.

Libon, F. (2021). Quid des peaux foncées? Comment répondre aux changements dermatologiques dus à l’âge? La routine de l’adolescent, Derrière le masque, les dégâts, La peau de bébé, fragile et immature.

GIET, G., SENTERRE, Y., LEBAS, E., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (September 2021). Le phénomène de Köbner en Dermatologie. Revue Médicale de Liège, 76 (9), 651 - 656.

Libon, F., LEBAS, E., DE SCHAETZEN VAN BRIENEN, V., SABATIELLO, M., De Schepper, S., & NIKKELS, A. (30 July 2021). Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients. Expert Review of Clinical Immunology, 17. doi:10.1080/1744666X.2021.1958675
Peer Reviewed verified by ORBi

Libon, F., DEZFOULIAN, B., & NIKKELS, A. (27 May 2021). Le dupilumab diminue la fréquence et la sévérité des infections herpétiques chez les patients atteints de dermatite atopique [Paper presentation]. 16e Congrès Francophone d'Allergologie, Paris, France.

Absil, G., DAMSIN, T., LEBAS, E., Libon, F., SOMJA, J., COLLINS, P., REGINSTER, M.-A., QUATRESOOZ, P., RORIVE, A., MARCHAL, N., JACQUEMIN, D., BOUS, A., PIRET, P., & NIKKELS, A. (May 2021). Le mélanome: le trajet de soins du patient: Du diagnostic au traitement. Revue Médicale de Liège, 76 (5-6), 489-495.
Editorial Reviewed verified by ORBi

Absil, G., Libon, F., Dezfoulian, B., & Nikkels, A. (05 March 2021). Dupilumab reduces frequency and severity of HSV recurrences in patients with atopic dermatitis [Poster presentation]. BDD 2021 Virtual Event, (virtual meeting), Belgium.

Libon, F. (2021). L'eczéma de contact. (Cours inter-universitaires).

LEBAS, E., COLLINS, P., BONNET, C., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (2021). Comment je traite… le mycosis fongoïde : à propos du brentuximab védotine, une nouvelle arme thérapeutique. Revue Médicale de Liège, 76 (4), 224-231.
Peer reviewed

Libon, F., Dezfoulian, B., & Nikkels, A. (2021). Le dupilumab diminue la fréquence et la sévérité des infections herpétiques chez les patients atteints de dermatite atopique [Poster presentation]. 16e Congrès Francophone d'Allergologie, Paris, France.

Absil, G., Libon, F., NIKKELS, A., & DEZFOULIAN, B. (24 October 2020). Fixed Drug Eruption to Piroxicam : About two cases [Paper presentation]. Belgian Contact an Environmental Dermatitis Group, Ixelles, Belgium.

Libon, F., LEBAS, E., EL HAYDERI, L., DE SCHAETZEN VAN BRIENEN, V., DEZFOULIAN, B., & NIKKELS, A. (March 2020). Les traitements actuels du psoriasis : de l’étanercept aux antagonistes anti-IL17 et -IL23. Revue Médicale de Liège, 75 (5-6), 376-381.

DEZFOULIAN, B., & Libon, F. (20 February 2020). DUPIXENT (dupilumab) A New Era in the Treatment of Severe Atopic Dermatitis [Paper presentation]. DUPIXENT (dupilumab) A New Era in the Treatment of Severe Atopic Dermatitis, Liège, Belgium.

Libon, F., NIKKELS, A., & DEZFOULIAN, B. (14 November 2019). Tables rondes "AbbVie en dermatologie" [Paper presentation]. Tables rondes "AbbVie en dermatologie", Liège, Belgium.

DEZFOULIAN, B., Libon, F., & NIKKELS, A. (February 2019). Le dosage sérique des IgE en dermatologie. Skin, 22 (1), 10-13.

DAMSIN, T., COLLIGNON, J., LEBAS, E., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (January 2019). Comment je traite... Les toxicités mucocutanées des thérapies ciblées en oncologie. Revue Médicale de Liège, 01, 7-14.
Peer reviewed

Vanhakendover, L., LEBAS, E., Libon, F., WAUTERS, O., Dezfoulian, B., MARCHAL, N., RORIVE, A., PIRET, P., Quatresooz, P., Jacquemin, D., & Nikkels, A. (2019). Carcinome spinocellulaire cutané localement avancé et métastatique traité par cemiplimab. Revue Médicale de Liège, 74 (7-8), 436-440.
Peer reviewed

Vanhakendover, L., LEBAS, E., Libon, F., WAUTERS, O., DEZFOULIAN, B., MARCHAL, N., RORIVE, A., PIRET, P., JACQUEMIN, D., & NIKKELS, A. (2019). Patient avec un carcinome spinocellulaire cutané localement avancé et métastatique traité par Cemiplimab. Revue Médicale de Liège, (74), 1-5.

Libon, F. (18 October 2018). Les vaccins en Dermatologie [Paper presentation]. Société Liégeoise de Dermatologie, Liège, Belgium.

DAMSIN, T., NIKKELS, A., Libon, F., & DEZFOULIAN, B. (13 October 2018). Precautions when reading the drug skin tests [Paper presentation]. Belgian Contact and Environmental Dermatis Group, Ixelles, Belgium.

Libon, F., Cavalier, E., & Nikkels, A. (September 2018). Skin color influences vitamin D synthesis [Poster presentation]. European Academy of Dermatology and Venerology (EADV), Paris, France.

Libon, F. (2018). Contribution à l’étude de la relation entre la vitamine D et la peau [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315215

Libon, F., & Nikkels, A. (2018). Polymorphous light eruption: Phototherapy-based desensitization versus intramuscular steroids - Who is right, who is wrong? Dermatology, 234 (5-6), 192-193. doi:10.1159/000492749
Peer Reviewed verified by ORBi

GIET, G., LEBAS, E., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (2018). Quoi de neuf dans le traitement de l'hidradénite suppurative en 2018? Revue Médicale de Liège.
Peer reviewed

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & NIKKELS, A. (2017). Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D. Archives of Osteoporosis. doi:10.1007/s11657-017-0361-0
Peer Reviewed verified by ORBi

Libon, F., Gadisseur, R., Nikkels, A., & Dezfoulian, B. (September 2017). Allergie au galactose-α 1,3 galactose [Poster presentation]. GERDA : Groupe d'études et de recherches en dermato-allergologie.

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., CAVALIER, E., Reginster, J.-Y., & NIKKELS, A. (March 2017). Effect of body surface, body site and sunscreen application on production of Vitamin D and 25-hydroxyvitamin D after a single narrowband UVB exposure. Osteoporosis International, 28 Suppl 1, 143-144.
Peer Reviewed verified by ORBi

Libon, F., COURTOIS, J., Le Goff, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & Nikkels, A. (2017). Effect of Body Site and Surface on Vitamin D and 25-Hydroxyvitamin D Production after a Single Narrowband UVB Exposure. Journal of Investigative Dermatology, 137 (6), 1391-1393. doi:10.1016/j.jid.2017.01.032
Peer Reviewed verified by ORBi

Libon, F., TASSOUDJI, N., DEZFOULIAN, B., ARRESE ESTRADA, J., & NIKKELS, A. (2017). Non-dermatophyte Dermatoses Mimicking Dermatophytoses in Humans. Mycopathologia, 182 (1-2), 101-111. doi:10.1007/s11046-016-0059-7
Peer Reviewed verified by ORBi

CASTRONOVO, C., ARRESE ESTRADA, J., Libon, F., TASSOUDJI, N., SEIDEL, L., Nikkels, A., & LEBAS, E. (2017). Prospective pilot evaluation of the efficacy and safety of topical ingenol mebutate gel for localized patch/plaque stage mycosis fungoides. Open Dermatology Journal, 11, 98-107. doi:10.2174/1874372201711010098
Peer reviewed

DETRIXHE, A., Libon, F., MANSUY, M., TASSOUDJI, N., RORIVE, A., ARRESE ESTRADA, J., QUATRESOOZ, P., REGINSTER, M.-A., & NIKKELS, A. (2016). Melanoma masquerading as nomelanocytic lesions. Melanoma Research. doi:10.1097/CMR.0000000000000294
Peer Reviewed verified by ORBi

Libon, F., LEBAS, E., ABDALLAH Rhim, ACCAPUTO Ornella, BOTT Ambre, BOUFFLETTE, N., CAO, S., CAPLANUSI Teofila, CASAGRANDA Aneline, CHAMOUN Alexandre, COLSON, F., COSTER Alison, COUTELIER Aurélie, DAXHELET Mathilde, BEBOIS Déborah, DEHAVAY Florence, DETRIXHE, A., EL NEMNOM Pamela, HELLGREN Guillaume, ... NIKKELS, A. (2016). Partie 1 : Les maladies bactériennes cutanées. Skin, 19 (6), 6-13.

LEBAS, E., Libon, F., & NIKKELS, A. (2015). Koebner Phenomenon and Mycosis Fungoides. Case Reports in Dermatology, 287-291. doi:10.1159/000440856
Peer Reviewed verified by ORBi

Libon, F., Courtois, J., LUKAS, P., LE GOFF, C., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (October 2015). Effect of body surface, body site and sunscreen application on production of vitamin D and 25-hydroxyvitamin D after a single narrowband-UVB exposure [Paper presentation]. EADV Congress, Cophenhague, Denmark.

Libon, F., Courtois, J., Le Goff, C., LUKAS, P., Seidel, L., Cavalier, E., & Nikkels, A. (October 2015). Effect of body surface area and sunscreen application on production of vitamin D after a single UVB-exposure [Poster presentation]. European Academy of Dermatology and Venerology (EADV), Copenhague, Denmark.

Libon, F., TASSOUDJI, N., DEZFOULIAN, B., ARRESE ESTRADA, J., & NIKKELS, A. (2015). Les kératoses actiniques : généralités. Skin.

EL HAYDERI, L., LIBON, F., TASSOUDJI, N., RUEBBEN, A., DEZFOULIAN, B., & NIKKELS, A. (2015). Zosteriform dermatoses-A review. Global Dermatology, 2 (4), 163-173.

RORIVE, A., EL HAYDERI, L., LIBON, F., DEZFOULIAN, B., JERUSALEM, G., NIKKELS, A., & LEBAS, E. (2015). VISMODEGIB ET CARCINOMES BASOCELLULAIRES LOCALEMENT AVANCES. Revue Médicale de Liège.
Peer reviewed

LIBON, F., EL HAYDERI, L., TASSOUDJI, N., DEZFOULIAN, B., & NIKKELS, A. (2015). La rosacée. Revue Médicale de Liège.
Peer reviewed

Libon, F., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (2015). Vitamin D supplementation does not improve the severity or the resolution of ultraviolet B-induced acute erythema. Dermatology, 231, 280-285. doi:10.1159/000430983
Peer Reviewed verified by ORBi

Libon, F., Cavalier, E., & Nikkels, A. (October 2014). Vitamin D and photoprotection [Paper presentation]. European Academy of Dermatology and Venerology (EADV), Amsterdam, Netherlands.

LIBON, F., DEZFOULIAN, B., & NIKKELS, A. (17 April 2014). Réaction immédiate à l'alcool [Poster presentation]. Congrès Francophone d'Allergologie (CFA), Paris, France.

Libon, F., Dezfoulian, B., Gadisseur, R., & Nikkels, A. (15 March 2014). Allergy to Erbitux ® (Cetuximab) [Paper presentation]. Belgian Contact and Environmental Dermatitis Group.

MALAISE, O., LIBON, F., BRICMAAN J, VON FRENCKELL, C., SIMONI, P., LEONARD P, & Malaise, M. (22 January 2014). Two spondylodiscitis due to a contamination by Brucella melitensis in a mother and daughter back from holidays. Revue Médicale de la Suisse Romande, 10 (404), 197-200.
Peer Reviewed verified by ORBi

PAQUET, P., JENNES, S., ROUSSEAU, A.-F., LIBON, F., DELVENNE, P., & PIERARD, G. (2014). Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study. Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2014.01.027
Peer Reviewed verified by ORBi

Libon, F. (2014). Vitamin D and dermatosis [Paper presentation]. service de Dermatologie de l’hôpital de Wuhan, Wuhan, China.

Libon, F. (December 2013). Les toxidermies bulleuses [Paper presentation]. Société Liégeoise de Dermatologie.

Libon, F., TASSOUDJI, N., Quatresooz, P., Reginster, M.-A., & Nikkels, A. (February 2013). Childhood bullous dermatosis [Paper presentation]. Société Royale Belge de Dermatologie, Gand, Belgium.

LIBON, F., CAVALIER, E., & NIKKELS, A. (2013). Skin color is relevant to vitamin D synthesis. Dermatology, 227 (3), 250-4. doi:10.1159/000354750
Peer Reviewed verified by ORBi

LIBON, F., COLSON, F., CAO, S., & NIKKELS, A. (2013). La dermoscopie digitalisée séquentielle dans la dermatologie d'aujourd'hui. Skin, 16 (N°5), 8-12.

LIBON, F., CAVALIER, E., & NIKKELS, A. (2013). La vitamine D et la peau. Revue Médicale de Liège, 68 (9), 458-464.
Peer reviewed

LIBON, F., ARRESE ESTRADA, J., RORIVET, A., & NIKKELS, A. (2012). Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases. Clinical and Experimental Dermatology, (4452), 1-4. doi:10.1111/j.1365-2230.2012.04452.x
Peer Reviewed verified by ORBi

LIBON, F., DEZFOULIAN, B., & NIKKELS, A. (2012). La photoprotection en 2012. Skin Inc.

Libon, F., RORIVE, A., & NIKKELS, A. (2011). L'ipilimumab, un progrès significatif dans le traitement du mélanome métastatique. Skin, 14.

Contact ORBi